Many clinical trials aren’t able to even move past the recruitment and enrollment stage. According to Deloitte, a “study on ...

The evidence-backed model delivered impressive results, but it doesn’t validate the wave of AI therapy bots flooding the ...

The importance of training data suggests that the flood of companies promising therapy via AI models, many of which are not ...

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the ...

For decades, women’s health has been overlooked in medical research, leading to misdiagnoses, ineffective treatments, and ...

Barriers to wider use of AI in oncology include inaccuracy, workflow challenges, environmental impacts, and more.

While some believe AI can be a helpful tool, others argue that the human touch of therapists and psychologists is irreplaceable. Despite this debate, the latest research from Dartmouth suggests ...

claims its AI model is similarly superior at analyzing breast cancer and colorectal cancer scans, potentially offering drugmakers a better way to design their clinical trials.

Artificial Intelligence is revolutionizing pharmaceuticals, accelerating drug discovery, and optimizing clinical trials. Yet, ...

Despite consistent improvements in glycemic outcomes across simulations, real-world adoption is lagging. The study finds that ...